Molecular mechanisms of diabetic cardiomyopathy

Most mammalian mRNAs are conserved targets of microRNAs

Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462

Development by Self-Digestion

Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,728

Diabetes and Cardiovascular Disease: The Framingham Study

Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936

Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury

Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261

The Framingham Study

Dawber, T. R. (1980) · Harvard University Press eBooks · doi:10.4159/harvard.9780674492097 · Cited by 1,965

Identification of hundreds of conserved and nonconserved human microRNAs

Bentwich, I., Avniel, A., Karov, Y., Aharonov, R., Gilad, S., Barad, O., Barzilai, A., Einat, P., Einav, U., Meiri, E., et al. (2005) · Nature Genetics · doi:10.1038/ng1590 · Cited by 1,841

New type of cardiomyopathy associated with diabetic glomerulosclerosis

Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,835

The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress

Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1574 · Cited by 1,520

Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus

Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1137 · Cited by 2,043

Metformin: from mechanisms of action to therapies

Foretz, M., Guigas, B., Bertrand, L., Pollak, M., & Viollet, B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.018 · Cited by 1,501

Mitochondrial dynamics in health and disease: mechanisms and potential targets

Chen, W., Zhao, H., & Li, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01547-9 · Cited by 1,306

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

Jia, G., DeMarco, V. G., & Sowers, J. R. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.216 · Cited by 976

Basic Mechanisms of Diabetic Heart Disease

Ritchie, R. H., & Abel, E. D. (2020) · Circulation Research · doi:10.1161/circresaha.120.315913 · Cited by 741

Heart Failure in Type 2 Diabetes Mellitus

Kenny, H., & Abel, E. D. (2019) · Circulation Research · doi:10.1161/circresaha.118.311371 · Cited by 682

Mitochondrial dynamics, mitophagy and cardiovascular disease

Vásquez-Trincado, C., García‐Carvajal, I., Pennanen, C., Parra, V., Hill, J. A., Rothermel, B. A., & Lavandero, S. (2015) · The Journal of Physiology · doi:10.1113/jp271301 · Cited by 637

Insulin Signaling and Heart Failure

Riehle, C., & Abel, E. D. (2016) · Circulation Research · doi:10.1161/circresaha.116.306206 · Cited by 420

Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association

Pop‐Busui, R., Januzzi, J. L., Bruemmer, D., Butalia, S., Green, J. B., Horton, W. B., Knight, C. M., Levi, M., Rasouli, N., & Richardson, C. R. (2022) · Diabetes Care · doi:10.2337/dci22-0014 · Cited by 442

Macrovascular Complications of Type 2 Diabetes Mellitus

Viigimaa, M., Sachinidis, A. G., Toumpourleka, M., Koutsampasopoulos, K., Alliksoo, S., & Titma, T. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190405165151 · Cited by 421

Melatonin prevents D rp1‐mediated mitochondrial fission in diabetic hearts through SIRT 1‐ PGC 1α pathway

Ding, M., Feng, N., Tang, D., Feng, J., Li, Z., Jia, M., Liu, Z., Gu, X., Wang, Y., Fu, F., et al. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12491 · Cited by 387

Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy

Marwick, T. H., Ritchie, R., Shaw, J. E., & Kaye, D. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.019 · Cited by 365

Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy

Knapp, M., Tu, X., & Wu, R. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0042-6 · Cited by 338

Beneficial Effects of Citrus Flavonoids on Cardiovascular and Metabolic Health

Mahmoud, A. M., Hernández-Bautista, R., Sandhu, M. A., & Hussein, O. E. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5484138 · Cited by 321

Diagnostic approaches for diabetic cardiomyopathy

Lorenzo-Almorós, A., Tuñón, J., Orejas, M., Cortés, M., Egido, J., & Lorenzo, Ó. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0506-x · Cited by 262

Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy

Kaludercic, N., & Lisa, F. D. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00012 · Cited by 268

Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy

Hu, L., Ding, M., Tang, D., Gao, E., Li, C., Wang, K., Qi, B., Qiu, J., Zhao, H., Chang, P., et al. (2019) · Theranostics · doi:10.7150/thno.33684 · Cited by 257

Diabetes, heart failure, and renal dysfunction: The vicious circles

D, E. B. M. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.07.003 · Cited by 252

Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology

Maack, C., Lehrke, M., Backs, J., Heinzel, F. R., Hulot, J., Marx, N., Paulus, W. J., Rossignol, P., Taegtmeyer, H., Bauersachs, J. K., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy596 · Cited by 255

Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers

Mechanick, J. I., Farkouh, M. E., Newman, J. D., & Garvey, W. T. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.044 · Cited by 243

Hsp20-Mediated Activation of Exosome Biogenesis in Cardiomyocytes Improves Cardiac Function and Angiogenesis in Diabetic Mice

Wang, X., Gu, H., Huang, W. C., Peng, J., Li, Y., Yang, L., Qin, D., Essandoh, K., Wang, Y., Peng, T., et al. (2016) · Diabetes · doi:10.2337/db15-1563 · Cited by 239

Anti-diabetic drugs recent approaches and advancements

Dowarah, J., & Singh, V. P. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115263 · Cited by 246

Emerging roles of exosomal miRNAs in diabetes mellitus

He, X., Kuang, G., Wu, Y., & Ou, C. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.468 · Cited by 234

Mitochondrial Structure and Function in Human Heart Failure

Hinton, A. O., Jr., Claypool, S. M., Neikirk, K., Senoo, N., Wanjalla, C. N., Kirabo, A., & Williams, C. R. (2024) · Circulation Research · doi:10.1161/circresaha.124.323800 · Cited by 239

Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy

Arow, M., Waldman, M., Yadin, D., Nudelman, V., Shainberg, A., Abraham, N. G., Freimark, D., Kornowski, R., Aravot, D. J., Hochhauser, E., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0980-4 · Cited by 220

lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy

Li, X., Wang, H., Yao, B., Xu, W., Chen, J., & Zhou, X. (2016) · Scientific Reports · doi:10.1038/srep36340 · Cited by 213

lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy

Zhou, X., Zhang, W., Jin, M., Chen, J., Xu, W., & Kong, X. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.321 · Cited by 201

Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy

Parim, B., Uddandrao, V. V. S., & Saravanan, G. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9749-1 · Cited by 197

Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients

Uthman, L., Baartscheer, A., Schumacher, C. A., Fiolet, J. W. T., Kuschma, M. C., Hollmann, M. W., Coronel, R., Weber, N. C., & Zuurbier, C. J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01575 · Cited by 190

Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting

Wilson, A. J., Gill, E. K., Abudalo, R. A., Edgar, K. S., Watson, C. J., & Grieve, D. (2017) · Heart · doi:10.1136/heartjnl-2017-311448 · Cited by 178

Combination of high-fat/high-fructose diet and low-dose streptozotocin to model long-term type-2 diabetes complications

Barrière, D. A., Noll, C., Roussy, G., Lizotte, F., Kessai, A., Kirby, K., Belleville, K., Beaudet, N., Longpré, J., Carpentier, A. C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18896-5 · Cited by 183

Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry

Echouffo-Tcheugui, J. B., Xu, H., DeVore, A. D., Schulte, P. J., Butler, J., Yancy, C. W., Bhatt, D. L., Hernandez, A. F., Heidenreich, P. A., & Fonarow, G. C. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.07.025 · Cited by 160

Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?

Hölscher, M. E., Bode, C., & Bugger, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122136 · Cited by 163

Mitochondrial Mechanisms in Septic Cardiomyopathy

Cimolai, M. C., Álvarez, S., Bode, C., & Bugger, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817763 · Cited by 158

CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats

Ma, Z., Yuan, Y., Xu, S., Wei, W., Xu, C., Zhang, X., Wu, Q., Liao, H.-H., Ni, J., & Tang, Q. (2017) · Diabetologia · doi:10.1007/s00125-017-4232-4 · Cited by 156

The role of SIRT1 in diabetic cardiomyopathy

Karbasforooshan, H., & Karimi, G. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.056 · Cited by 155

Upregulation of MG53 Induces Diabetic Cardiomyopathy Through Transcriptional Activation of Peroxisome Proliferation-Activated Receptor α

Liu, F., Song, R., Feng, Y., Guo, J., Chen, Y., Zhang, Y., Chen, T., Wang, Y., Huang, Y., Li, C., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.012285 · Cited by 147

MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy

Wang, Y., Luo, W., Han, J., Khan, Z. A., Fang, Q., Jin, Y., Chen, X., Zhang, Y., Wang, M., Qian, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15978-3 · Cited by 148

Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions

Huo, J., Feng, Q., Pan, S., Fu, W.-J., Liu, Z., & Liu, Z. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01553-4 · Cited by 148

USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart

Xie, S., Liu, S., Zhang, T., Shi, W., Xing, Y., Fang, W., Zhang, M., Chen, M.-Y., Xu, S., Fan, M.-Q., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.065603 · Cited by 147

In vivo administration of urolithin A and B prevents the occurrence of cardiac dysfunction in streptozotocin-induced diabetic rats

Savi, M., Bocchi, L., Mena, P. R., Dall’Asta, M., Crozier, A., Brighenti, F., Stilli, D., & Rio, D. D. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0561-3 · Cited by 141

Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection

Ussher, J. R., Baggio, L. L., Campbell, J. E., Mulvihill, E. E., Kim, M., Kabir, M. G., Cao, X., Baranek, B. M., Stoffers, D. A., Seeley, R. J., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.04.009 · Cited by 144

Mitochondrial Mechanisms in Diabetic Cardiomyopathy

Gollmer, J., Zirlik, A., & Bugger, H. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0185 · Cited by 139

Regulated cell death pathways in cardiomyopathy

Sheng, S., Li, J., Hu, X., & Wang, Y. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01068-9 · Cited by 135

Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy

Wang, H., Wang, J., Cui, H., Fan, C., Xue, Y., Liu, H., Li, H., Li, J., Li, H., Sun, Y., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01036-5 · Cited by 136

Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats

Lee, T.-I., Chen, Y., Lin, Y., Chung, C., Lu, Y., Kao, Y., & Chen, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071680 · Cited by 130

Mitochondrial Reactive Oxygen Species Mediate Cardiac Structural, Functional, and Mitochondrial Consequences of Diet‐Induced Metabolic Heart Disease

Sverdlov, A. L., Elezaby, A., Qin, F., Behring, J. B., Luptak, I., Calamaras, T. D., Siwik, D. A., Miller, E. J., Liesa, M., Shirihai, O. S., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002555 · Cited by 135

FGF1ΔHBS prevents diabetic cardiomyopathy by maintaining mitochondrial homeostasis and reducing oxidative stress via AMPK/Nur77 suppression

Wang, D., Yin, Y., Wang, S., Zhao, T., Gong, F., Zhao, Y., Wang, B., Huang, Y., Cheng, Z., Zhu, G., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00542-2 · Cited by 131

Melatonin activates Parkin translocation and rescues the impaired mitophagy activity of diabetic cardiomyopathy through Mst1 inhibition

Wang, S., Zhao, Z., Feng, X., Cheng, Z., Xiong, Z., Wang, T., Lin, J. M., Zhang, M., Hu, J., Fan, Y., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13802 · Cited by 131

Inflammation in diabetes complications: molecular mechanisms and therapeutic interventions

Zhao, L., Hu, H., Zhang, L., Liu, Z., Huang, Y., Liu, Q., Jin, L., Zhu, M., & Zhang, L. (2024) · MedComm · doi:10.1002/mco2.516 · Cited by 141

Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications

Yamagishi, S., Fukami, K., & Matsui, T. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0176-5 · Cited by 127

Mechanisms of Kaempferol in the treatment of diabetes: A comprehensive and latest review

Yang, Y., Chen, Z., Zhao, X., Xie, H., Du, L., Gao, H. L., & Xie, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.990299 · Cited by 140

Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice

Xue, F., Cheng, J., Liu, Y., Cheng, C., Zhang, M., Sui, W., Chen, W., Hao, P., Zhang, Y., & Zhang, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01054-3 · Cited by 123

Type 2 Diabetes and Heart Failure: Challenges and Solutions

Thomas, M. C. (2016) · Current Cardiology Reviews · doi:10.2174/1573403x12666160606120254 · Cited by 117

A Novel Circular RNA Mediates Pyroptosis of Diabetic Cardiomyopathy by Functioning as a Competing Endogenous RNA

Yang, F., Li, A., Qin, Y., Che, H., Wang, Y., Lv, J., Li, Y., Li, H., Yue, E., Ding, X., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.06.026 · Cited by 120

Inhibiting Insulin-Mediated β 2 -Adrenergic Receptor Activation Prevents Diabetes-Associated Cardiac Dysfunction

Wang, Q., Liu, Y., Fu, Q., Xu, B. Y., Zhang, Y., Kim, S., Tan, R., Barbagallo, F., West, T. M., Anderson, E. J., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022281 · Cited by 120

Autophagy Inhibition Enables Nrf2 to Exaggerate the Progression of Diabetic Cardiomyopathy in Mice

Zang, H., Wu, W., Qi, L., Tan, W., Nagarkatti, P. S., Nagarkatti, M., Wang, X., & Cui, T. (2020) · Diabetes · doi:10.2337/db19-1176 · Cited by 115

Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway

Zhang, C., Huang, Z., Gu, J., Yan, X., Lu, X., Zhou, S., Wang, S., Shao, M., Zhang, F., Cheng, P., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3630-8 · Cited by 113

Alternative Mitophagy Protects the Heart Against Obesity-Associated Cardiomyopathy

Tong, M., Saito, T., Zhai, P., Oka, S.-I., Mizushima, W., Nakamura, M., Ikeda, S., Shirakabe, A., & Sadoshima, J. (2021) · Circulation Research · doi:10.1161/circresaha.121.319377 · Cited by 113

New Molecular Insights of Insulin in Diabetic Cardiomyopathy

Westermeier, F., Riquelme, J. A., Pávez, M., Garrido, V., Díaz, A., Verdejo, H., Castro, P., García, L., & Lavandero, S. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00125 · Cited by 114

Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects

Palmiero, G., Cesaro, A., Vetrano, E., Pafundi, P. C., Galiero, R., Caturano, A., Moscarella, E., Gragnano, F., Salvatore, T., Rinaldi, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115863 · Cited by 124

Emerging roles of ferroptosis in cardiovascular diseases

Wang, K., Chen, X., Wang, Y.-H., Cheng, X., Zhao, Y., Zhou, L., & Wang, K. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01183-2 · Cited by 117

Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms

Huang, K., Luo, X., Liao, B., Li, G., & Feng, J. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01816-5 · Cited by 117

Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study

Elder, D. H. J., Singh, J. S. S., Levin, D., Donnelly, L. A., Choy, A.-M., George, J., Struthers, A. D., Doney, A. S. F., & Lang, C. C. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.455 · Cited by 109

Curcumin, A Polyphenolic Curcuminoid With Its Protective Effects and Molecular Mechanisms in Diabetes and Diabetic Cardiomyopathy

Zheng, J., Cheng, J., Zheng, S., Feng, Q., & Xiao, X. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00472 · Cited by 111

Andrographolide Protects against HG-Induced Inflammation, Apoptosis, Migration, and Impairment of Angiogenesis via PI3K/AKT-eNOS Signalling in HUVECs

Duan, M., Zhou, H., Wu, Q., Liu, C., Xiao, Y., Deng, W., & Tang, Q. (2019) · Mediators of Inflammation · doi:10.1155/2019/6168340 · Cited by 110

Histone deacetylases in cardiovascular and metabolic diseases

Bagchi, R. A., & Weeks, K. L. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.04.003 · Cited by 109

Mesenchymal stem cells promote type 2 macrophage polarization to ameliorate the myocardial injury caused by diabetic cardiomyopathy

Jin, L., Deng, Z., Zhang, J.-Y., Yang, C., Liu, J.-J., Han, W.-D., Ye, P., Si, Y., & Chen, G.-H. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1999-8 · Cited by 95

Doxorubicin-induced cardiotoxicity and risk factors

Belger, C., Abrahams, C., Imamdin, A., & Lecour, S. (2023) · International Journal of Cardiology: Heart & Vasculature · doi:10.1016/j.ijcha.2023.101332 · Cited by 113

Down-regulation of lncRNA MALAT1 reduces cardiomyocyte apoptosis and improves left ventricular function in diabetic rats

Zhang, M., Gu, H., Xu, W., & Zhou, X. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.136 · Cited by 106

LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR‐34a in diabetic cardiomyopathy

Gao, L., Wang, X., Guo, S., Xiao, L., Liang, C., Zheng, W., Li, Y., Liu, Y., Yao, R., Liu, Y., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27296 · Cited by 106

LncRNAs: key players and novel insights into diabetes mellitus

He, X., Ou, C., Xiao, Y., Han, Q., Li, H., & Zhou, S. (2017) · Oncotarget · doi:10.18632/oncotarget.19921 · Cited by 103

Cilia‐localized LKB1 regulates chemokine signaling, macrophage recruitment, and tissue homeostasis in the kidney

Viau, A., Bienaimé, F., Lukas, K., Todkar, A., Knoll, M., Yakulov, T. A., Hofherr, A., Kretz, O., Helmstädter, M., Reichardt, W., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798615 · Cited by 112

Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects

Kaplan, A., Abidi, E., EL‐Yazbi, A. F., Eid, A. H., Booz, G. W., & Zouein, F. A. (2018) · Heart Failure Reviews · doi:10.1007/s10741-017-9665-9 · Cited by 108

Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention

Guo, R., & Nair, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.03.013 · Cited by 103

Flavonoids improve type 2 diabetes mellitus and its complications: a review

Yi, X., Dong, M., Guo, N., Tian, J., Lei, P., Wang, S., Yang, Y., & Shi, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1192131 · Cited by 118

Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure

Johansson, I., Dahlström, U., Edner, M., Näsman, P., Rydén, L., & Norhammar, A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.061 · Cited by 100

Kaempferol attenuates hyperglycemia-induced cardiac injuries by inhibiting inflammatory responses and oxidative stress

Chen, X., Qian, J., Wang, L., Li, J., Zhao, Y., Han, J., Khan, Z. A., Chen, X., Wang, J., & Liang, G. (2018) · Endocrine · doi:10.1007/s12020-018-1525-4 · Cited by 100

Molecular mechanisms of cardiac pathology in diabetes – Experimental insights

Varma, U., Koutsifeli, P., Benson, V. L., Mellor, K. M., & Delbridge, L. M. D. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.035 · Cited by 102

Pathophysiological Fundamentals of Diabetic Cardiomyopathy

Hu, X., Bai, T., Xu, Z., Liu, Q., Zheng, Y., & Cai, L. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160021 · Cited by 103

Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages

Tate, M., Robinson, E., Green, B. D., McDermott, B. J., & Grieve, D. J. (2016) · Basic Research in Cardiology · doi:10.1007/s00395-015-0518-1 · Cited by 96

Multiple Tissue-specific Roles for the O-GlcNAc Post-translational Modification in the Induction of and Complications Arising from Type II Diabetes

Vaidyanathan, K., & Wells, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.591560 · Cited by 96

Are targeted therapies for diabetic cardiomyopathy on the horizon?

Tate, M., Grieve, D., & Ritchie, R. H. (2017) · Clinical Science · doi:10.1042/cs20160491 · Cited by 96

Molecular and Biochemical Pathways of Catalpol in Alleviating Diabetes Mellitus and Its Complications

Bhattamisra, S. K., Koh, H. M., Lim, S. Y., Choudhury, H., & Pandey, M. (2021) · Biomolecules · doi:10.3390/biom11020323 · Cited by 96

Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2

Jin, L., Zhang, J., Deng, Z., Liu, J., Han, W., Chen, G., Si, Y., & Ye, P. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01633-7 · Cited by 95

Maternal high-fat diet impairs cardiac function in offspring of diabetic pregnancy through metabolic stress and mitochondrial dysfunction

Mdaki, K. S., Larsen, T. D., Wachal, A. L., Schimelpfenig, M. D., Weaver, L. J., Dooyema, S. D. R., Louwagie, E. J., & Baack, M. L. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00795.2015 · Cited by 94

Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate

Hroob, A. M. A., Abukhalil, M. H., Hussein, O. E., & Mahmoud, A. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.086 · Cited by 96

circRNAs Signature as Potential Diagnostic and Prognostic Biomarker for Diabetes Mellitus and Related Cardiovascular Complications

Zaiou, M. (2020) · Cells · doi:10.3390/cells9030659 · Cited by 95

Cardiomyopathy Associated with Diabetes: The Central Role of the Cardiomyocyte

Filardi, T., Ghinassi, B., Baldassarre, A. D., Tanzilli, G., Morano, S., Lenzi, A., Basili, S., & Crescioli, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133299 · Cited by 94

Role of protein carbonylation in diabetes

Hecker, M., & Wagner, A. H. (2017) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-017-0104-9 · Cited by 92

Metabolic and Molecular Imaging of the Diabetic Cardiomyopathy

Peterson, L. R., & Gropler, R. J. (2020) · Circulation Research · doi:10.1161/circresaha.120.315899 · Cited by 93

Piceatannol alleviates inflammation and oxidative stress via modulation of the Nrf2/HO-1 and NF-κB pathways in diabetic cardiomyopathy

Li, H., Shi, Y., Wang, X., Li, P., Zhang, S., Wu, T., Yan, Y., Zhan, Y., Ren, Y., Rong, X., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108754 · Cited by 89

The Mitochondria in Diabetic Heart Failure: From Pathogenesis to Therapeutic Promise

Schilling, J. D. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6294 · Cited by 90

Ginsenoside Rg1 ameliorates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress‐induced apoptosis in a streptozotocin‐induced diabetes rat model

Yu, H., Zhen, J., Yang, Y., Gu, J., Sui-sheng, W., & Liu, Q. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12739 · Cited by 88

Insulin Inhibits Cardiac Contractility by Inducing a Gi-Biased β2-Adrenergic Signaling in Hearts

Fu, Q., Xu, B. Y., Liu, Y., Parikh, D., Li, J., Li, Y., Zhang, Y., Riehle, C., Zhu, Y., Rawlings, T. A., et al. (2014) · Diabetes · doi:10.2337/db13-1763 · Cited by 87

Pathogenetic mechanisms of septic cardiomyopathy

Wang, R., Xu, Y., Fang, Y., Wang, C., Xue, Y., Wang, F., Jin, C. S., Ren, H., Wang, J., Guo, W., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30527 · Cited by 87

Metabolic stress-induced cardiomyopathy is caused by mitochondrial dysfunction due to attenuated Erk5 signaling

Liu, W., Ruiz‐Velasco, A., Wang, S., Khan, S., Zi, M., Jungmann, A., Camacho‐Muñoz, D., Guo, J., Du, G., Xie, L., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00664-8 · Cited by 88

Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain

Cao, Y., Zeng, W., Cui, Y., Kong, X., Wang, M., Yu, J., Zhang, S., Song, J., Xu, Y., Greiser, A., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0651-2 · Cited by 84

Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants

Prandi, F. R., Evangelista, I., Sergi, D., Palazzuoli, A., & Romeo, F. (2022) · Heart Failure Reviews · doi:10.1007/s10741-021-10200-y · Cited by 86

Hydrogen sulfide attenuates myocardial fibrosis in diabetic rats through the JAK/STAT signaling pathway

Liu, M., Li, Y., Liang, B., Li, Z., Jiang, Z., Chu, C., & Yang, J. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3419 · Cited by 82

[Diabetic cardiomyopathy: pathophysiological mechanisms of structural and functional changes.]

Slavı́ková, J., Mistrová, E., & Chottová, M. D. (2016) · PubMed

Of mice and men: models and mechanisms of diabetic cardiomyopathy

Riehle, C., & Bauersachs, J. K. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0711-0 · Cited by 204

Molecular Mechanisms in the Pathogenesis of Diabetic Cardiomyopathy

Chakrabarti, S. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7130-2_27

Current understanding of structural and molecular changes in diabetic cardiomyopathy

Akhtar, M. S., Alavudeen, S. S., Raza, A., Imam, M. T., Almalki, Z. S., Tabassum, F., & Iqbal, M. J. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122087 · Cited by 23

Established and Emerging Mechanisms of Diabetic Cardiomyopathy

Gollmer, J., Zirlik, A., & Bugger, H. (2019) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2019.8.1.26 · Cited by 31